Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Riluzole in Treatment-Resistant Depression
NCT01204918Phase 2Completed
- Sponsor
- Yale University
- Start
- Jun 2011
- Primary completion
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of riluzole in major depressive disorder (MDD), sponsored by Yale University. Started Jun 2011; status: completed.
02
Drugs
riluzole
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT01204918.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01204918.